In re Reglan Litigation, 226 N.J. 315 (2016).  Plaintiffs in this mass tort matter claimed that defendants, who are generic manufacturers of metoclopramide, the generic version of the drug Reglan, were liable under New Jersey’s Product Liability Act, N.J.S.A. 2A:58C-1 to -11 (“PLA”), for failure to warn about the health effects of taking metoclopramide for too long.  The warning on the generics’ labels differed from the warning that the Food and Drug Administrat

Catena v. Raytheon Company, 447 N.J. Super. 43 (App. Div. 2016).  The time when a cause of action accrues, for purposes of triggering the statute of limitations, is a recurring and often thorny one.  Most of the cases arise in the context of negligence cases.  Today’s decision, however, by Judge Ostrer, involved common law fraud and a claim under the Consumer Fraud Act, N.J.S.A. 56:8-2 (“CFA”), both in connection with environmental issues.

Plaintiff had bou

The Supreme Court has granted certification of class certification decisions in two cases under the Consumer Fraud Act, N.J.S.A. 56:8-1 et seq., and the Truth in Consumer Contract, Warranty, and Notice Act, N.J.S.A. 56:12-14 et seq.  One of the cases, Dugan v. TGI Friday’s, Inc., 445 N.J. Super. 59 (App. Div. 2016), was discussed here, in a post that suggested the result in the Appellate Division was incorrect.  The othe